Spyre Therapeutics, Inc. - Common Stock (NQ: SYRE )

22.92 +0.24 (+1.06%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	462,061
Open	22.78
Bid (Size)	21.70 (1)
Ask (Size)	25.31 (1)
Prev. Close	22.68
Today's Range	22.43 - 23.19
52wk Range	20.07 - 47.97
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

SPYRE ALERT: Bragar Eagel & Squire, P.C. is Investigating Spyre Therapeutics, Inc. on Behalf of Spyre Stockholders and Encourages Investors to Contact the Firm

December 03, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

SYRE Stock Earnings: Spyre Therapeutics Beats EPS for Q2 2024

August 07, 2024

SYRE stock results show that Spyre Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Performance

YTD	-3.90%	-3.90%
1 Month	+11.53%	+11.53%
3 Month	-20.06%	-20.06%
6 Month	-17.70%	-17.70%
1 Year	-1.29%	-1.29%

More News

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

July 18, 2024

From NewAmsterdam Pharma N.V.

Via GlobeNewswire

SYRE Stock Earnings: Spyre Therapeutics Misses EPS for Q1 2024

May 09, 2024

Via InvestorPlace

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday

March 05, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.